TOLREMO therapeutics

About:

TOLREMO therapeutics is a developer of small molecules intended to target novel drug resistance pathways in cancer therapy.

Website: http://www.tolremo.com

Top Investors: Zürcher Kantonal Bank, Altos Ventures, redalpine, BioMedPartners, Pierre Fabre Invest

Description:

TOLREMO therapeutics is a developer of small molecules intended to target novel drug resistance pathways in cancer therapy.The company's molecules specifically eradicate those cancer cells that cause drug resistance, enabling physicians to get personalized anti-drug resistance therapies to meaningfully prolong the lives of cancer patients.